A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
Condition(s):Postmenopausal OsteoporosisLast Updated:May 12, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Postmenopausal OsteoporosisLast Updated:May 12, 2016Completed
Condition(s):Breast Cancer; Hypercalcemia of Malignancy; Metastatic Cancer; PainLast Updated:November 13, 2013Withdrawn
Condition(s):Lung CancerLast Updated:February 17, 2016Terminated
Condition(s):Hepatic Osteodystrophy; Liver CirrhosisLast Updated:September 1, 2023Not yet recruiting
Condition(s):Rheumatoid Arthritis; Osteoporosis; OsteopeniaLast Updated:November 19, 2014Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:January 28, 2009Completed
Condition(s):OsteoporosisLast Updated:November 5, 2013Completed
Condition(s):HIV InfectionsLast Updated:March 13, 2019Withdrawn
Condition(s):Postmenopausal OsteoporosisLast Updated:February 11, 2013Completed
Condition(s):Hematological MalignanciesLast Updated:September 13, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.